Abstract:Background and purpose:Local recurrence is one of treatment failure cause for nasopharyngeal carcinoma(NPC).Further treatments for locally recurrent NPC are available,such as surgery,chemotherapy,targeted therapy and radiotherapy is the most important of all.There are several radiotherapy methods,including conventional external beam,brachytherapy,three-dimensional conformal and intensity modulated radiotherapy.This study retrospectively analyzed the long-term outcomes and late radiation injuries of locally recurrent NPC that were treated with hyperfractionated intracavitary brachytherapy or combined with external beam radiotherapy for the purpose of assessing the value of hyperfractionated intracavitary brachytherapy.Methods:Sixty-nine patients were enrolled to restaged T1(51 cases) and T2(18 cases) of locally recurrent NPC.Twenty patients received hyperfractionated intracavitary brachytherapy with a median dosage of 50 Gy(ranged 40-50 Gy).The remaining 49 patients received external beam radiotherapy with a median dosage of 50 Gy(ranged 30-65 Gy) plus hyperfractionated intracavitary brachytherapy with the median dose of 20 Gy(ranged 8-48 Gy) boosted.Two courses of brachytherapy were delivered,each consisting of 2.5-3.0 Gy per fraction,each of the 2 fractions were spaced 6 hours apart and lasting for 5 days.The second course of brachytherapy was delivered after one week of rest.Results:The 3 and 5-year overall survival rates were 59.66% and 39.66%.The 3 and 5-year local tumor control rates were 86.3% and 77.2%,respectively.After the reirradiation,the incidence rates for nasopharyngeal ulceration,trismus,lower cranial nerve palsy and radiation encephalopathy were 26.1%,39.1%,30.4% and 13.0%,respectively.Cases of trismus and nasopharyngeal ulceration in the brachytherapy group versus in the combined group were 4 versus 23(P=0.038) and 6 versus 12(P=0.636),respectively.Conclusion:Hyperfractionated intracavitary brachytherapy is feasible for locally recurrent nasopharyngeal carcinoma that is restaged early.The 5-year overall survival and local tumor control rates were 39.66% and 77.2%.Hyperfractionated intracavitary brachytherapy can be recommended for rT1 and rT2 locally recurrent nasopharyngeal carcinoma.

Hyperfractionated High Dose Rate Interstitial Brachytherapy for Carcinoma of the Oral Cavity and Orophanynx

Study on Interstitial Brachytherapy Combined with External Beam Radiation for Nasopharyngeal Carcinoma Patients Residual with Involvement of the Parapharyngeal Space

[Long-Term Efficacy of External Radiotherapy Plus Intracavitary Hyperfractionated Brachytherapy on Nasopharyngeal Carcinoma].

Randomized Clinical Study on 192 Iridium High Dose Rate Intrabronchial Brachytherapy for Lung Cancer on the Basis of Bronchial Artery Infusion and Radiotherapy

Long-term efficacy of hyperfractionated intracavitary brachytherapy on 69 patients with locally recurrent nasopharyngeal carcinoma

Image-guided interstitial brachytherapy for recurrent cervical cancer after radiotherapy: A single institution experience

3D-CT implanted interstitial brachytherapy for T2b nasopharyngeal carcinoma

3D-image-guided HDR-brachytherapy versus 2D HDR - brachytherapy after external beam radiotherapy for early T-stage nasopharyngeal carcinoma

Combined external radiotherapy and single-fraction palliative high-dose-rate interstitial brachytherapy for a patient with a base of tongue cancer who had a previous radiation history

PO-0965: 125I Seeds Implantation under Ultrasound Guidance for Local Recurrent Tumor of Head and Neck

Results of sole postoperative interstitial, high-dose-rate brachytherapy of T1–2 tongue tumours

Analysis of Phase Ⅲ Randomized Trial of Conventional Irradiaton Versus Hyperfractionated Irradiation with Late Course Concomitant Boost in Nasopharyngeal Carcinoma

Preliminary Application of 192 Ir High-Dose Rate Brachytherapy in Postoperative Recurrent Colorectal Cancer with Intrapulmonary Oligometastases

Prognostic factors for IB2-IIIB cervical cancer patients treated by radiation therapy with high-dose-rate brachytherapy in a single-institution study

Efficacy and safety of 3-dimensional printing noncoplanar template (3D-PNCT)-assisted high-dose-rate interstitial brachytherapy (HDR-ISBT) for reirradiation of recurrent cervical cancer: a prospective cohort

Intracavity Hyperthermia In Nasopharyngeal Cancer: A Phase Iii Clinical Study

Adjuvant pulse-dose-rate brachytherapy for oral cavity and oropharynx carcinoma: Outcome and toxicity assessment of 66 patients

Preliminary Results of (125)I Interstitial Brachytherapy for Locally Recurrent Parotid Gland Cancer in Previously Irradiated Patients.

Application of 192Ir brachytherapy in locally recurrent non-small cell lung cancer

Primary Study of Planning Intensity Modulated Radiation Therapy Combined with Intracavitary Brachytherapy for Early Stage of Nasopharyngeal Carcinoma

Interstitial Brachytherapy for the Residual or Recurrent Cervical Lymph Nodes after Irradiation of Nasopharyngeal Carcinoma